Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.9650 (1.16%) ($13.9650 - $13.9650) on Wed. Aug. 31, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.27% (three month average) | RSI | 45 | Latest Price | $13.9650(1.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(33%) VT(32%) VUG(32%) BLOK(30%) URA(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.135% in a week (0% probabilities). VIXM(-16%) UUP(-14%) SMH(-10%) VXX(-3%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.135% (StdDev 4.27%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $14.31 | 5 Day Moving Average | $14.16(-1.38%) | 10 Day Moving Average | $14.23(-1.86%) | 20 Day Moving Average | $14.31(-2.41%) | To recent high | -5.8% | To recent low | 53.7% | Market Cap | $2.464b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |